NCT00006146View on ClinicalTrials.gov

Half-Dose Flu Vaccine Study in Healthy Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

840

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

September 30, 2000

Conditions
Influenza
Interventions
BIOLOGICAL

Approved influenza virus vaccine.

Trial Locations (6)

14642

Univ of Rochester Medical Center, Rochester

45206

Inf Dis Clinic at Gamble Research Clinic and Bethesda Hosp, Cincinnati

63110

Center for Vaccine Development, St Louis

77030

Baylor College of Medicine, Houston

90502

UCLA Center for Vaccine Research, Torrance

Unknown

Maryland CARES, College Park

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00006146 - Half-Dose Flu Vaccine Study in Healthy Adults | Biotech Hunter | Biotech Hunter